American Century Companies Inc Neogenomics Inc Transaction History
American Century Companies Inc
- $168 Billion
- Q4 2024
A detailed history of American Century Companies Inc transactions in Neogenomics Inc stock. As of the latest transaction made, American Century Companies Inc holds 2,893,261 shares of NEO stock, worth $34.3 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
2,893,261
Previous 3,025,944
4.38%
Holding current value
$34.3 Million
Previous $44.6 Million
6.83%
% of portfolio
0.03%
Previous 0.03%
Shares
25 transactions
Others Institutions Holding NEO
# of Institutions
282Shares Held
124MCall Options Held
751KPut Options Held
107K-
Black Rock Inc. New York, NY19.7MShares$233 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.2MShares$169 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.53MShares$77.4 Million0.07% of portfolio
-
Janus Henderson Group PLC London, X06.17MShares$73.1 Million0.05% of portfolio
-
Brown Advisory Inc6.16MShares$73 Million0.13% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.49B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...